Bacteria
Chlamydia pneumoniae
Chlamydia pneumoniae is an obligate intracellular Gram-negative bacterium and an important cause of so-called atypical respiratory tract infections.

O patogenu
Chlamydia pneumoniae is an obligate intracellular Gram-negative bacterium and an important cause of so-called atypical respiratory tract infections. It can cause pharyngitis, sinusitis and bronchitis, but is particularly associated with community-acquired pneumonia, which often has a gradual onset with persistent dry cough, fever or low-grade fever, fatigue and headache. The clinical course may be prolonged and can overlap with Mycoplasma pneumoniae infection.
Serological diagnosis is based on the assessment of specific IgM, IgG and IgA antibodies and their dynamics over time. IgM supports the detection of early primary infection, whereas IgG appears later and persists long term; seroconversion or a fourfold increase in IgG titres in paired sera provides important evidence of recent infection. During reinfection, IgM may be absent and IgG levels may rise more rapidly. IgA can provide additional diagnostic information, particularly in suspected ongoing, recurrent or persistent infection. For accurate interpretation, the individual antibody classes should therefore be evaluated together and in the context of the clinical presentation.
VIDIA offers a comprehensive solution for the serological diagnosis of Chlamydia pneumoniae: ELISA-VIDITEST and MONO-VIDITEST assays for the detection of specific IgA, IgG and IgM antibodies.
Portfolio
Dostupné assays
Portfolio pro tento patogen průběžně doplňujeme. Napište nám na obchod@vidia.cz a pošleme dostupné varianty.
Časté otázky
Často kladené otázky
What is Chlamydia pneumoniae and what symptoms does it typically cause?
Chlamydia pneumoniae is an obligate intracellular bacterium and a significant cause of upper and lower respiratory tract infections. It is transmitted mainly by respiratory droplets and can cause pharyngitis, laryngitis, sinusitis, bronchitis or community-acquired atypical pneumonia. The infection can run asymptomatically or with only mild, nonspecific symptoms. Typical features are gradually developing cough, sore throat, hoarseness, headache, fatigue, malaise and low-grade fever; the cough can persist for several weeks. Repeat infections are possible, because past infection does not create reliable long-term sterilizing immunity.
How does interpretation of IgM, IgG and IgA antibodies differ for this pathogen?
In primary infection, IgM appears first, usually within about 2 to 4 weeks, and gradually declines after the acute infection, typically over 2 to 6 months. Its presence therefore supports a diagnosis of early primary infection. The IgG response develops later, usually at around 6 to 8 weeks, and can persist for years; isolated IgG positivity therefore generally documents prior contact and does not by itself prove acute infection. IgA also appears at around 6 to 8 weeks, but its persistence tends to be shorter. A rise in IgA can support suspicion of active, recurrent or persistent infection.
How does the serological picture differ in reinfection compared with primary infection?
Primary infection typically shows a relatively slow sequence of IgM followed by IgG/IgA. In reinfection, memory B lymphocytes already exist, so the IgG and IgA response can rise very quickly, within about 1 to 2 weeks, while the IgM response tends to be low or may be absent altogether. When reinfection is suspected, it is therefore more appropriate to assess the dynamics of IgG and IgA in paired sera than to expect a pronounced IgM response. Serology also demonstrates the immune response rather than the direct presence of the bacterium, and must be interpreted together with the clinical picture and, where relevant, molecular diagnostics.
When does it make sense to add IgA to a standard IgG/IgM panel?
IgA is of greatest value where reinfection, or a recurrent or prolonged infection, is suspected and IgM is negative or only low. In reinfection, IgA can rise quickly together with IgG, while a pronounced IgM response may not develop. IgA should therefore not be interpreted in isolation as a definitive marker of chronic infection. It is a supplementary parameter whose value increases when evaluated together with IgG, IgM, titer dynamics, the clinical picture and, where relevant, other laboratory methods.
What type of sample does the test require?
VIDIA ELISA-VIDITEST anti-Chlamydia pneumoniae IgA, IgG and IgM are intended for testing human serum or plasma.
How long does it take to get a result?
All three kits use a unified protocol of 30/30/15 minutes, that is 75 minutes of incubation. The method is compatible with automated processing on the ThunderBolt analyzer.
Nenašli jste, co hledáte?
Pomůžeme Vám najít vhodné diagnostické řešení
Popište nám, co potřebujete vyšetřit, a náš produktový tým Vám pomůže najít vhodné diagnostické řešení. Odpovíme Vám do 24 hodin.
Preferujete e-mail? Napište nám na obchod@vidia.cz
